位置:首页 > 蛋白库 > LTO1_YEAST
LTO1_YEAST
ID   LTO1_YEAST              Reviewed;         162 AA.
AC   P53846; D6W0T3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2018, sequence version 2.
DT   03-AUG-2022, entry version 133.
DE   RecName: Full=Protein LTO1 {ECO:0000303|PubMed:23318452, ECO:0000305};
DE   AltName: Full=LTO1 family protein YNL260C {ECO:0000305};
GN   Name=LTO1 {ECO:0000303|PubMed:23318452}; OrderedLocusNames=YNL260C;
GN   ORFNames=N0838;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 96604 / S288c / FY1679;
RX   PubMed=9234673;
RX   DOI=10.1002/(sici)1097-0061(199707)13:9<849::aid-yea106>3.0.co;2-n;
RA   Sen-Gupta M., Gueldener U., Beinhauer J.D., Fiedler T.A., Hegemann J.H.;
RT   "Sequence analysis of the 33 kb long region between ORC5 and SUI1 from the
RT   left arm of chromosome XIV from Saccharomyces cerevisiae.";
RL   Yeast 13:849-860(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169873;
RA   Philippsen P., Kleine K., Poehlmann R., Duesterhoeft A., Hamberg K.,
RA   Hegemann J.H., Obermaier B., Urrestarazu L.A., Aert R., Albermann K.,
RA   Altmann R., Andre B., Baladron V., Ballesta J.P.G., Becam A.-M.,
RA   Beinhauer J.D., Boskovic J., Buitrago M.J., Bussereau F., Coster F.,
RA   Crouzet M., D'Angelo M., Dal Pero F., De Antoni A., del Rey F., Doignon F.,
RA   Domdey H., Dubois E., Fiedler T.A., Fleig U., Floeth M., Fritz C.,
RA   Gaillardin C., Garcia-Cantalejo J.M., Glansdorff N., Goffeau A.,
RA   Gueldener U., Herbert C.J., Heumann K., Heuss-Neitzel D., Hilbert H.,
RA   Hinni K., Iraqui Houssaini I., Jacquet M., Jimenez A., Jonniaux J.-L.,
RA   Karpfinger-Hartl L., Lanfranchi G., Lepingle A., Levesque H., Lyck R.,
RA   Maftahi M., Mallet L., Maurer C.T.C., Messenguy F., Mewes H.-W., Moestl D.,
RA   Nasr F., Nicaud J.-M., Niedenthal R.K., Pandolfo D., Pierard A.,
RA   Piravandi E., Planta R.J., Pohl T.M., Purnelle B., Rebischung C.,
RA   Remacha M.A., Revuelta J.L., Rinke M., Saiz J.E., Sartorello F.,
RA   Scherens B., Sen-Gupta M., Soler-Mira A., Urbanus J.H.M., Valle G.,
RA   Van Dyck L., Verhasselt P., Vierendeels F., Vissers S., Voet M.,
RA   Volckaert G., Wach A., Wambutt R., Wedler H., Zollner A., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV and its
RT   evolutionary implications.";
RL   Nature 387:93-98(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14690591; DOI=10.1016/s1097-2765(03)00476-3;
RA   Hazbun T.R., Malmstroem L., Anderson S., Graczyk B.J., Fox B., Riffle M.,
RA   Sundin B.A., Aranda J.D., McDonald W.H., Chiu C.-H., Snydsman B.E.,
RA   Bradley P., Muller E.G.D., Fields S., Baker D., Yates J.R. III, Davis T.N.;
RT   "Assigning function to yeast proteins by integration of technologies.";
RL   Mol. Cell 12:1353-1365(2003).
RN   [5]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [6]
RP   FUNCTION, INTERACTION WITH YAE1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLU-11; PHE-18; LEU-19; GLN-50; VAL-57; LYS-83; PHE-94; LEU-101; ASN-103;
RP   HIS-113; ARG-134; ASN-146 AND GLU-147.
RX   PubMed=23318452; DOI=10.1038/onc.2012.604;
RA   Zhai C., Li Y., Mascarenhas C., Lin Q., Li K., Vyrides I., Grant C.M.,
RA   Panaretou B.;
RT   "The function of ORAOV1/LTO1, a gene that is overexpressed frequently in
RT   cancer: essential roles in the function and biogenesis of the ribosome.";
RL   Oncogene 33:484-494(2014).
RN   [7]
RP   FUNCTION, INTERACTION WITH YAE1 AND THE CIA COMPLEX, MUTAGENESIS OF ASP-4;
RP   17-GLY--GLY-21; 33-GLY--GLY-41; 49-GLY--GLY-53 AND TRP-162, AND
RP   IDENTIFICATION OF INITIATION SITE.
RX   PubMed=26182403; DOI=10.7554/elife.08231;
RA   Paul V.D., Muehlenhoff U., Stuempfig M., Seebacher J., Kugler K.G.,
RA   Renicke C., Taxis C., Gavin A.C., Pierik A.J., Lill R.;
RT   "The deca-GX3 proteins Yae1-Lto1 function as adaptors recruiting the ABC
RT   protein Rli1 for iron-sulfur cluster insertion.";
RL   Elife 4:E08231-E08231(2015).
CC   -!- FUNCTION: Essential for life in oxygen, but nonessential under
CC       anaerobic conditions. Required for biogenesis of the large ribosomal
CC       subunit and initiation of translation in oxygen (PubMed:23318452). The
CC       complex LTO1:YAE1 functions as a target specific adapter that recruits
CC       apo-RLI1 to the cytosolic iron-sulfur protein assembly (CIA) complex
CC       machinery (PubMed:26182403). {ECO:0000269|PubMed:23318452,
CC       ECO:0000269|PubMed:26182403}.
CC   -!- SUBUNIT: Forms a complex with YAE1; the complex bridges the interaction
CC       between the CIA complex and RLI1 (PubMed:23318452). Associates with the
CC       CIA complex (via its C-terminal tryptophan) (PubMed:26182403).
CC       {ECO:0000269|PubMed:23318452, ECO:0000269|PubMed:26182403}.
CC   -!- INTERACTION:
CC       P53846; P47118: YAE1; NbExp=2; IntAct=EBI-28226, EBI-25522;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23318452}.
CC   -!- MISCELLANEOUS: Present with 784 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the LTO1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA65484.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA96167.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=DAA10299.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X96722; CAA65484.1; ALT_INIT; Genomic_DNA.
DR   EMBL; Z71536; CAA96167.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BK006947; DAA10299.1; ALT_INIT; Genomic_DNA.
DR   PIR; S63233; S63233.
DR   RefSeq; NP_014139.1; NM_001183098.1.
DR   AlphaFoldDB; P53846; -.
DR   SMR; P53846; -.
DR   BioGRID; 35579; 129.
DR   DIP; DIP-4273N; -.
DR   IntAct; P53846; 5.
DR   MINT; P53846; -.
DR   STRING; 4932.YNL260C; -.
DR   PaxDb; P53846; -.
DR   PRIDE; P53846; -.
DR   EnsemblFungi; YNL260C_mRNA; YNL260C; YNL260C.
DR   GeneID; 855461; -.
DR   KEGG; sce:YNL260C; -.
DR   SGD; S000005204; YNL260C.
DR   eggNOG; KOG4595; Eukaryota.
DR   HOGENOM; CLU_136375_0_0_1; -.
DR   InParanoid; P53846; -.
DR   BioCyc; YEAST:G3O-33256-MON; -.
DR   ChiTaRS; LTO1; yeast.
DR   PRO; PR:P53846; -.
DR   Proteomes; UP000002311; Chromosome XIV.
DR   RNAct; P53846; protein.
DR   GO; GO:0005737; C:cytoplasm; HDA:SGD.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0062092; C:Yae1-Lto1 complex; IDA:SGD.
DR   GO; GO:0106035; P:protein maturation by [4Fe-4S] cluster transfer; IDA:UniProtKB.
DR   InterPro; IPR019191; Essential_protein_Yae1_N.
DR   Pfam; PF09811; Yae1_N; 1.
PE   1: Evidence at protein level;
KW   Nucleus; Reference proteome.
FT   CHAIN           1..162
FT                   /note="Protein LTO1"
FT                   /id="PRO_0000203382"
FT   REGION          17..53
FT                   /note="deca-GX3 motif; required for interaction with YAE1
FT                   and the CIA complex"
FT                   /evidence="ECO:0000269|PubMed:26182403"
FT   MUTAGEN         4
FT                   /note="D->A: No effect on interaction with YAE1 or the CIA
FT                   complex. No effect on iron incorporation into RLI1."
FT                   /evidence="ECO:0000269|PubMed:26182403"
FT   MUTAGEN         11
FT                   /note="E->G: Lethal at 37 degrees Celsius; when associated
FT                   with P-19, E-83, L-113 and G-147. Lethal at 37 degrees
FT                   Celsius; when associated with R-0, R-50, L-94, S-101 and S-
FT                   146."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         17..21
FT                   /note="GFLEG->AFLEA: Slightly decreases interaction with
FT                   YAE1 and the CIA complex. No effect on iron incorporation
FT                   into RLI1."
FT                   /evidence="ECO:0000269|PubMed:26182403"
FT   MUTAGEN         18
FT                   /note="F->L: Lethal at 37 degrees Celsius; when associated
FT                   with D-57, D-103 and G-134."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         19
FT                   /note="L->P: Lethal at 37 degrees Celsius; when associated
FT                   with G-11, E-83, L-113 and G-147."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         33..41
FT                   /note="GKQYGLQVG->AKQYALQVA: Decreases interaction with
FT                   YAE1 and the CIA complex. Abolishes iron incorporation into
FT                   RLI1."
FT                   /evidence="ECO:0000269|PubMed:26182403"
FT   MUTAGEN         49..53
FT                   /note="GQMEG->AQMEA: Decreases interaction with YAE1 and
FT                   the CIA complex. Strongly decreases iron incorporation into
FT                   RLI1."
FT                   /evidence="ECO:0000269|PubMed:26182403"
FT   MUTAGEN         50
FT                   /note="Q->R: Lethal at 37 degrees Celsius; when associated
FT                   with G-11, L-94, S-101 and S-146."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         57
FT                   /note="V->D: Lethal at 37 degrees Celsius; when associated
FT                   with L-18, D-103 and G-134."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         83
FT                   /note="K->E: Lethal at 37 degrees Celsius; when associated
FT                   with G-11, P-19, L-113 and G-147."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         94
FT                   /note="F->L: Lethal at 37 degrees Celsius; when associated
FT                   with G-11, R-50, S-101 and S-146."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         101
FT                   /note="L->S: Lethal at 37 degrees Celsius; when associated
FT                   with G-11, R-50, L-94 and S-146."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         103
FT                   /note="N->D: Lethal at 37 degrees Celsius; when associated
FT                   with L-18, D-57 and G-134."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         113
FT                   /note="H->L: Lethal at 37 degrees Celsius; when associated
FT                   with G-11, P-19, E-83 and G-147."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         134
FT                   /note="R->G: Lethal at 37 degrees Celsius; when associated
FT                   with L-18, D-57 and D-103."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         146
FT                   /note="N->S: Lethal at 37 degrees Celsius; when associated
FT                   with G-11, R-50,L-94 and S-101."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         147
FT                   /note="E->G: Lethal at 37 degrees Celsius; when associated
FT                   with G-11, P-19, E-83 and L-113."
FT                   /evidence="ECO:0000269|PubMed:23318452"
FT   MUTAGEN         162
FT                   /note="W->A: Abolishes interaction with the CIA complex. No
FT                   effect on interaction with YAE1. Strongly decreases iron
FT                   incorporation into RLI1."
FT                   /evidence="ECO:0000269|PubMed:26182403"
SQ   SEQUENCE   162 AA;  18896 MW;  63FCBF5B30ABC714 CRC64;
     MDFDNLLNLE EQYYQEGFLE GQNENIKQSF LEGKQYGLQV GFQRFTLLGQ MEGLCDVIES
     YGLHSPTLEK NIHTIRTLMK GLKMNNDDES VMEFERVLIK LKNKFRTILI TLHRLVKDKR
     TPTVTFEVFE DVSRAIAGEI RGFVENEDIA KNKTKQNQAQ SW
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024